Moderna
MRNA
#1308
Rank
NZ$28.59 B
Marketcap
NZ$73.17
Share price
-5.95%
Change (1 day)
3.39%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$28.59 Billion

As of February 2026 Moderna has a market cap of NZ$28.59 Billion. This makes Moderna the world's 1308th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$28.59 B35.83%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Moderna was reported to be:

NZ$28.58 Billion
by Nasdaq info icon info icon
NZ$28.59 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$909.08 B 3,079.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$473.68 B 1,556.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$457.32 B 1,499.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.93 B-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$4.94 B-82.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.38 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$74.15 B 159.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$16.11 B-43.63%๐Ÿ‡บ๐Ÿ‡ธ USA